The Senate Finance Committee held on Tuesday the third in a series of hearings on drug pricing in America, which focused on the role of pharmacy benefit managers. 
  
"PBMs negotiate with the drug companies, as well as pharmacies, to arrive at a price for a drug and its ultimate cost," said Committee Chairman Chuck Grassley, R-Iowa. "This system of private entities negotiating is what I envisioned as an author of the Part D program. I still believe this is absolutely the right approach. ... However, it's our duty to understand how the system is working today and what we can do to improve it." 
  
Ranking Member Ron Wyden, D-Ore., said, "PBMs are supposed to be negotiators who get better deals on prescription drugs for patients. What they are is middlemen who've raked in profits while drug prices have shot into the stratosphere. And as most people will tell you, there are already too many middlemen taking a cut in the American health care system." 
  
Testifying at the hearing were Steve Miller, M.D., executive vice president and chief clinical officer of Cigna; Derica Rice, executive vice president of CVS Health and president of CVS Caremark; William Fleming, segment president, health care services at Humana; John Prince, CEO of OptumRx; and Mike Kolar, interim president and CEO at Prime Therapeutics.

Related News Articles

Headline
Health and Human Services Secretary Alex Azar today released a plan outlining two pathways the administration intends to explore to safely import certain drugs…
Headline
The Senate Finance Committee today voted 19-9 to pass the Prescription Drug Pricing Reduction Act, legislation to reduce drug costs.
Headline
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the…
Headline
The House Energy and Commerce Committee today approved legislation to address surprise medical bills and Medicaid disproportionate share hospital cuts.
Headline
The Trump administration today withdrew a proposed rule that would eliminate the rebate safe harbor for pharmacy benefit managers under the federal anti-…
Headline
A federal judge yesterday struck down a Centers for Medicare…